Precision Therapeutics Announces Results of Special Meeting of Stockholders

    NEXT STORY
    Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedback
    PREV STORY
    CytomX Therapeutics Announces Transition of Chief Financial Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    ContraFect to Present at the 2019 Janney Healthcare Conference

    author_avatar
    NASDAQ Market News

    International Association for the Study of Lung Cancer第十八届World Conference on Lung Cancer摘要征集通知

    丹佛, Sept. 09, 2017 (GLOBE NEWSWIRE) -- International Association for the Study of Lung ...

    author_avatar
    NASDAQ Market News

    Amarin’s REDUCE-IT™ Clinical Study Now Positioned to be Next Large Cardiovascular Outcomes Study to Report Results

    REDUCE-IT is the First Study of Any Therapy to Prospectively Enroll and Evaluate Risk ...

    author_avatar
    NASDAQ Market News